Benzodiazepines Tied to Worse Outcomes in Progressive Supranuclear Palsy
People with progressive supranuclear palsy (PSP) who were prescribed benzodiazepine derivatives had a faster decline in PSP Rating Scale (PSPRS) scores than those who didn’t have benzodiazepines, a post hoc analysis showed. In a secondary analysis of concomitant drugs used in a phase II/III clinical trial, only one medication class — benzodiazepine derivatives, including lorazepam, […]